The global generic drug trade lobby may pull out of the International Conference of Harmonisation unless it gets a seat on ICH's standards-setting steering committee, which issues quality guidelines that affect biosimilar and generic drug companies, the lobby group warns in an Aug. 8 letter to ICH. The International Generic Pharmaceutical Alliance is upset that ICH in a recent meeting decided to shut the generic drug industry out the steering committee, which includes regulators and brand-name drug industry officials from...